Browsing Tag

Pfizer

StockWatch: J&J Pause Vaccination Jabs

The US, South Africa, and the EU will temporarily stop the rollout of the Johnson & Johnson covid-19 jab, after reports of rare blood clotting. As a result, J&J has paused its EU rollout which started this week. One company’s…

StockWatch: Pfizer Pill Enters Phase 1

Pfizer​ has initiated the Phase I trial of an anti-Covid​-19 pill that could be given to patients showing early signs of illness. The pill could be used in the early treatment of coronavirus​ disease​ and to address future threats.…

Pfizer Rallies As EU Snubs AZ-Oxford Jab

Shares in Drugmaker Pfizer are trading a little lower ahead of the market open at the start of the week. Despite the sales, Pfizer shares have been higher over recent weeks. Price rallied up off the 2021 lows of around 33 though prices…

StockWatch: Pfizer Gets a Boost

The European​ Commission​ expects to receive more than 200m​ doses of Covid​-19 vaccines from Pfizer​ in Q2, putting the EU​ on course to meet its inoculation​ target. With this, the EU aims to vaccinate at least 255 million people, or…

Pfizer Shares Rally On UK Vaccine Approval

Shares in Pfizer are trading around 4% higher pre-market on Wednesday following news that the UK government has approved the vaccine developed by itself and German partner firm BioNTech. The UK government is now the first in the world to…